by Eric Christianson | Aug 5, 2026 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
I’m always on the lookout for new options to treat pain. This is especially true in geriatrics, where opioids and NSAIDs have a bunch of risks. Suzetrigine (Journavx) represents a newer option in pain management in recent years because it introduces an entirely...
by Eric Christianson | Jul 12, 2026 | Neurology, Pain, and Musculoskeletal Case Studies
Duplicate therapy is a common occurance in practice. It is something that frustrates me quite a bit. There are quite a few reasons why it happens. Some of the most common reasons for duplicate opioids include: Hospital discharge: A patient is started on a new opioid...
by Eric Christianson | Dec 11, 2024 | Renal, Urology, and Electrolytes Case Studies
I get a little nervous when I see high-dose potassium. Here’s a case scenario where a patient is on a higher dose. WL is a 77 year old male in an assisted living facility. He has a history of CHF, anxiety, pain, GERD, BPH, and constipation. His current...
by Eric Christianson | Sep 11, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Opvee (nalmefene), is an intranasal opioid antagonist used for opioid overdose and was approved by the FDA in 2023. This approval provided another tool to aid in combating the opioid crisis. There are currently two medications, Opvee and Narcan (naloxone), that can...
by Eric Christianson | Jun 26, 2024 | Clinical Pharmacy News and New Drug Updates, Psychiatry and Addiction Medication and Disease State Clinical Pearls
I’ve encountered a significant proportion of patients who are on chronic benzodiazepines. Drug interactions, adverse effects, and other risks to my geriatric patient population are significant when using this class of medication. Benzodiazepine withdrawal is...
